These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25434598)

  • 1. Antithrombotic therapy after left atrial appendage closure.
    Schmidt B; Chun KR
    Expert Rev Cardiovasc Ther; 2015 Jan; 13(1):105-9. PubMed ID: 25434598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey.
    Tilz RR; Potpara T; Chen J; Dobreanu D; Larsen TB; Haugaa KH; Dagres N
    Europace; 2017 Oct; 19(10):1737-1742. PubMed ID: 29016910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic strategies after interventional left atrial appendage closure: an update.
    Chen S; Weise FK; Chun KRJ; Schmidt B
    Expert Rev Cardiovasc Ther; 2018 Sep; 16(9):675-678. PubMed ID: 30095350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous left atrial appendage occlusion: New perspectives for the method.
    Gorczyca-Michta I; Wożakowska-Kapłon B
    Cardiol J; 2017; 24(5):554-562. PubMed ID: 28281734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation.
    Landmesser U; Holmes DR
    Eur Heart J; 2012 Mar; 33(6):698-704. PubMed ID: 22041550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous closure of the left atrial appendage for prevention of thromboembolism in atrial fibrillation for patients with contraindication to or failure of oral anticoagulation: a single-center experience.
    Faustino A; Paiva L; Providência R; Trigo J; Botelho A; Costa M; Leitão-Marques A
    Rev Port Cardiol; 2013 Jun; 32(6):461-71. PubMed ID: 23639325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion.
    Lewalter T; Kanagaratnam P; Schmidt B; Rosenqvist M; Nielsen-Kudsk JE; Ibrahim R; Albers BA; Camm AJ
    Europace; 2014 May; 16(5):626-30. PubMed ID: 24798956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
    Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus document: Percutaneous left atrial appendage occlusion in patients with nonvalvular atrial fibrillation: indications, patient selection, competences, organization, and operator training].
    Casu G; Gulizia MM; Molon G; Mazzone P; Audo A; Casolo G; Di Lorenzo E; Portoghese M; Pristipino C; Ricci RP; Themistoclakis S; Padeletti L; Tondo C; Berti S; Oreglia JA; Gerosa G; Zanobini M; Ussia GP; Musumeci G; Romeo F; Di Bartolomeo R
    G Ital Cardiol (Rome); 2016; 17(7-8):594-613. PubMed ID: 27571335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based percutaneous closure of the left atrial appendage in patients with atrial fibrillation.
    Leal S; Moreno R; de Sousa Almeida M; Silva JA; Lopez-Sendon JL
    Curr Cardiol Rev; 2012 Feb; 8(1):37-42. PubMed ID: 22845814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic Therapy and Device-Related Thrombosis Following Endovascular Left Atrial Appendage Closure.
    Saw J; Nielsen-Kudsk JE; Bergmann M; Daniels MJ; Tzikas A; Reisman M; Rana BS
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1067-1076. PubMed ID: 31103535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombosis on a left atrial appendage occluder device: the double-edged sword of stroke prevention strategies in atrial fibrillation.
    Ciconte G; Conti M; Baldi M; Saviano M; Vicedomini G; Pappone C
    J Cardiovasc Med (Hagerstown); 2017 Nov; 18(11):920-921. PubMed ID: 28937581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Atrial Appendage Closure in Patients with Atrial Fibrillation and Previous Intracerebral Hemorrhage.
    Renou P; Thambo JB; Iriart X; Nicot S; Kabore N; Jalal Z; Olindo S; Debruxelles S; Poli M; Rouanet F; Sibon I
    J Stroke Cerebrovasc Dis; 2017 Mar; 26(3):545-551. PubMed ID: 28041899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic Management After Left Atrial Appendage Closure: Current Evidence and Future Perspectives.
    Mesnier J; Cepas-Guillén P; Freixa X; Flores-Umanzor E; Hoang Trinh K; O'Hara G; Rodés-Cabau J
    Circ Cardiovasc Interv; 2023 May; 16(5):e012812. PubMed ID: 37192309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial Experience With Non-Vitamin K Antagonist Oral Anticoagulants for Short-Term Anticoagulation After Left Atrial Appendage Closure Device.
    Barakat AF; Wazni OM; Saliba WI; Saqi B; Abdur Rehman K; Tarakji K; Bassiouny M; Kanj M; Lindsay BD; Hussein AA
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1472-1473. PubMed ID: 29759681
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiplatelet effects of aspirin and clopidogrel after left atrial appendage (LAA) occluder implantation.
    Dannenberg L; Mourikis P; Naguib D; Zako S; Helten C; M'Pembele R; Trojovsky K; Konsek D; Wolff G; Brockmeyer M; Schulze V; Levkau B; Hohlfeld T; Zeus T; Kelm M; Polzin A
    Int J Cardiol; 2019 Jan; 275():95-100. PubMed ID: 30509374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the WATCHMAN left atrial appendage closure device.
    Alli O; Holmes D
    Expert Rev Med Devices; 2014 Nov; 11(6):541-51. PubMed ID: 25060590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic and anticoagulant therapy for atrial fibrillation.
    Dzeshka MS; Lip GY
    Cardiol Clin; 2014 Nov; 32(4):585-99. PubMed ID: 25443239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventional left atrial appendage closure vs novel anticoagulation agents in patients with atrial fibrillation indicated for long-term anticoagulation (PRAGUE-17 study).
    Osmancik P; Tousek P; Herman D; Neuzil P; Hala P; Stasek J; Haman L; Kala P; Poloczek M; Branny M; Chovancik J; Cervinka P; Holy J; Vancura V; Rokyta R; Taborsky M; Kovarnik T; Zemanek D; Peichl P; Haskova S; Jarkovsky J; Widimsky P;
    Am Heart J; 2017 Jan; 183():108-114. PubMed ID: 27979034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.